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PURPOSE. To compare the hemifield asymmetry of visual field (VF) loss in primary open-angle
glaucoma (POAG) and primary angle-closure glaucoma (PACG) across all severity levels.
METHODS. A total of 522 eyes of 327 patients with POAG (mean age 6 SD, 54.1 6 12.4 years)
and 375 eyes of 204 patients with PACG (67.36 8.9 years) were included. Subjects meeting the
definitions of POAG or PACG were included. Means of the total deviation (TD) values
(Humphrey 24-2 VF) in the Glaucoma Hemifield Test (GHT) regions were calculated in early (‡
6 dB), moderate (< 6 dB and ‡ 12 dB), and advanced (< 12 dB) stages of POAG and
PACG eyes. Then the differences of the TD values between superior and inferior hemifield GHT
regions of POAG and PACG eyes were calculated. Also, the relationship between the values of
pattern SD (PSD) and mean TD (mTD) was compared between POAG and PACG.
RESULTS. In POAG eyes in the early stage, three regions (central, paracentral, and peripheral) in
the superior hemifield had greater loss than their inferior counterparts; in moderate and
advanced stages, all GHT regions in the superior hemifield had greater loss than their inferior
counterparts. In PACG eyes, siginificantly fewer regions in the superior hemifield were
significantly worse than their inferior counterpart, compared with POAG: one region (central)
in early stage, two regions (central and peripheral) in moderate stage, and one region (central)
in advanced stage. POAG eyes had greater PSD values than PACG eyes for given mean of TD
values.
CONCLUSIONS. In both POAG and PACG eyes, VF damage was more pronounced in superior
hemifield than inferior hemifield; however, this tendency was more obvious in POAG eyes
than in PACG eyes.
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Glaucoma is the second leading cause of blindnessworldwide after cataract.1–3 Primary glaucoma is catego-
rized into disease types with respect to the status of the
iridocorneal angle: primary open-angle glaucoma (POAG) and
primary angle-closure glaucoma (PACG). The prevalence of
POAG and PACG varies across the world.2,4,5 POAG is more
predominant in most populations, with a prevalence of
approximately 3.5% in those between 40 and 80 years old,6
whereas the prevalence of PACG is approximately 0.9%.2
Although the prevalence of POAG is higher, patients with PACG
have a 3-fold greater risk of developing blindness compared
with POAG.2,6–8 As a result, it is estimated that 4.5 million
people are bilaterally blind due to POAG, whereas that number
is 3.9 million people with PACG, worldwide.2 This is
problematic in specific areas. A high prevalence of PACG has
been reported in Alaskan natives,9 Asia,6,9 Myanmar,10 and
Mongolia.11,12
It is well documented that the major risk factor for
developing glaucoma is raised IOP; however, in POAG, there
are other proposed non-IOP risk factors, including low systemic
blood pressure, myopia, and also vulnerability at the optic
disc.13–15 On the other hand, in PACG, elevated IOP secondary
to angle closure is the fundamental disease mechanism.12
Reflecting this, hyperopia is a risk factor for the development of
PACG,16–18 although contradicting results have also been
reported,19–21 whereas myopia is a risk factor for POAG.15
The difference in disease mechanisms is also supported by
different genetic associations; single nucleotide polymorphisms
identified in PACG, such as PLEKHA7 and COL11A1,22,23 are
different from those in POAG, although the detailed pathogenic
function of these genes is still unknown.
The clinical course of the disease is also very different
between POAG and PACG eyes. The development of PACG
requires elevated IOP, which is usually preventable if the angle-
closure process is resolved before irreversible trabecular
damage occurs, usually through laser peripheral iridotomy
and/or cataract extraction, although it has been reported that
the visual field (VF) can continue to deteriorate, despite well-
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controlled pressure.24 On the other hand, in POAG, although
IOP lowering slows the rate of VF progression, individuals can
continue to progress.25–29 Furthermore, when there is fast VF
progression in POAG, trabeculectomy is often performed even
if IOP is in the normal range with medical treatments, aiming
for a further reduction of IOP. Probably reflecting these
differences in pathogenesis, the optic discs often show
different characteristics between POAG and PACG eyes. For
instance, it has been reported that the prevalence of
peripapillary atrophy is higher and the peripapillary atrophy–
to–disc area ratio is significantly larger in the POAG group
compared with the chronic PACG group with no evidence of
an acute attack.30 Also, PACG eyes can have a pale disc;
although optic disc pallor is usually a feature of acute angle
closure, there is evidence that the optic disc may be pale in
chronic PACG eyes.30
All of these findings suggest different disease mechanisms
for POAG and PACG, which may be reflected on the patterns of
VF damage. Although both in POAG31,32 and PACG,33 VF
damage is more pronounced in the superior than the inferior
hemifield, the pattern of VF defects in POAG and PACG may
differ. There are several previous studies that reported that
PACG eyes had diffuse VF damage compared with POAG34–36;
however, these studies included a relatively small number of
eyes; fewer than 110 POAG eyes and fewer than 50 PACG eyes.
There is just one previous report analyzing more than 100 eyes
both in POAG and PACG groups37; however, the comparison of
VF damage was carried out in each of early, moderate, and
advanced stages, so the comparison was made using no more
than 30 eyes at each severity level. Thus, these findings need
confirmation in a further study with larger sample sizes in both
glaucoma groups. There are other studies that investigated the
pattern(s) of VF loss in POAG and PACG eyes from large
cohorts; however, these studies included only one of the
disease types.34,38 Thus, the purpose of the current study was
to compare the patterns of VF loss in a large number of POAG
(522 eyes) and PACG eyes (375 eyes).
METHODS
The VFs collected from POAG and PACG patients were
analyzed. The eyes were stratified to three severity levels:
early, moderate, and advanced. The VF asymmetry for each
POAG and PACG eye was calculated pointwise and in the GHT
regions. VF asymmetry was defined as the sensitivity difference
between the superior and inferior hemifields; the total
deviation (TD) values in the inferior hemifield (pointwise or
regionwise) were subtracted from the corresponding TD
values at the superior hemifield. The superior-inferior VF
asymmetry of POAG eyes and PACG eyes were calculated and
the patterns of VF asymmetry in each severity level in POAG
and PACG were determined and their statistical significance
was established.
POAG and PACG Subjects
The review boards of both institutes of the Tokyo University
Hospital and the Ryukyus University Hospital reviewed and
approved the study protocol. This study complied with the
tenets of the Declaration of Helsinki. Written consent was
given by patients for their information to be stored in the
hospital database and used for research; otherwise, based on
the regulations of the Japanese Guidelines for Epidemiologic
Study 2008 issued by the Japanese Government, the study
protocols did not require each patient to provide written
informed consent, instead the protocol was posted at the
outpatient clinic to notify participants about the study.
All of the VF records were retrospectively obtained from
medical records of participants who visited either the Tokyo
University Hospital or Ryukyus University Hospital between
1998 and 2016. Using the electronic records of both institutes,
all patients with POAG and PACG who satisfied the following
criteria were identified: (1) glaucoma was the only disease
causing VF damage, (2) at least two reliable VF measurements
with the Humphrey Field Analyzer II (HFA; Carl Zeiss Meditec,
Inc., Dublin, CA, USA) using either the 24-2 or 30-2 pattern and
the SITA standard program, and (3) presence of an abnormal
VF following Anderson-Patella’s criteria.39
We included eyes with best-corrected visual accuity (VA)
better than than 0.5 logMAR (Snellen equivalent approximately
6/18). POAG was defined as (1) the presence of typical
glaucomatous changes in the optic nerve head, such as a rim
notch with a rim width 0.1 disc diameter or a vertical cup-to-
disc ratio of >0.7 and/or a retinal nerve fiber layer defect with
its width at the optic nerve head margin greater than a major
retinal vessel, diverging in an arcuate or wedge shape, with a
VF defect suggestive of glaucoma40; and (2) as gonioscopic
wide open angles of grade 3 or 4 based on the Shaffer
classification; IOP was not a diagnostic criterion. Exclusion
criteria were being younger than 20 years, and (2) having
possible secondary ocular hypertension in either eye. PACG
was defined as the presence of angle closure (at least 180
degree of the posterior pigmented trabecular meshwork not
visible on gonioscopy in the primary position of gaze with no
indentation) with glaucomatous optic neuropathy (defined as
loss of neuroretinal rim with a vertical cup-to-disc ratio of
greater than 0.7 or between-eye vertical cup-to-disc ratio
asymmetry of greater than 0.2, focal notching of the neuro-
retinal rim) with a VF defect suggestive of glaucoma.40 Eyes
with a history of IOL surgery or acute angle closure or IOP
greater than 30 mm Hg were excluded. All of the IOP records
before the VF measurements were collected from medical
record, and the maximum IOP was calculated accordingly
(maximum IOP).
Visual Fields
The first VFs were excluded from the analysis (due to learning
effect), and only reliable VF tests were included. Reliable VF
was defined as 33% fixation losses and 15% false-positive
results, following a previous study that performed similar
analyses. When VFs were obtained with the 30-2 test pattern,
only the central 52 test locations corresponding to the 24-2 test
pattern were used in the analysis. Then the mean of TD (mTD)
of the 52 test points was calculated.
Both for POAG and PACG, eyes were stratified into three
groups according to the severity of the average of TD values:
early glaucoma (mTD value equal to or better than 6 dB),
moderate glaucoma (mTD value worse than 6 dB and better
than 12 dB) and advanced glaucoma (mTD value equal or
worse than12 dB).41 Then the entire VF was divided into 10
regions: a central, a paracentral, a nasal, and two peripheral
(arcuate 1 and arcuate 2) regions in each of superior and
inferior hemifields, derived from the Glaucoma Hemifield Test
(GHT) and also following previous studies (see Fig. 1).37,38 The
average of TD values in each of these 10 clusters was
calculated, as well as those in the entire superior and inferior
hemifields.
Statistical Analysis
Demographics of the groups were compared using the
generalized estimating equation (GEE) model with Gaussian
function for continuous variables, and with binomial function
for categorical (binary) variables. Essentially, the GEE model is
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very similar to ordinary linear regression (OLR) in describing
the relationship between the predictor variables and an
outcome variable. However, OLR analysis makes the general
assumption that all observations are independent of each
other. In the current study, measurements are nested within
subjects (both eyes from some subjects) and, thus, dependent
on each other. Ignoring this grouping of the measurements will
result in the underestimation of standard errors of regression
coefficients. The GEE adjusts for the hierarchical structure of
the data, modeling in a way in which measurements are
grouped within subjects. In addition, the confounding
variables of mean TD and sex were also controlled in the
GEE model to minimize their effects on the outcome.
Within-Group and Between-Group Comparisons
In the pointwise analysis, each VF test location in the superior
hemifield was compared with its counterpart (symmetrical
over the horizontal line) location in the inferior hemifield, and
the VF superior-inferior asymmetry was calculated (as TD value
in the inferior hemifield minus TD value in the superior
hemifield) for POAG and PACG eyes using the GEE model
controlling for the nested structure of two eyes in a patient and
mTD. The between-group comparison was carried out by
comparing the VF asymmetry patterns in POAG and PACG
groups using the GEE model, accounting for sex, refractive
error, maximum IOP, and visual acuity.
Likewise, in the regionwise analysis, the average of TD
values in the central, paracentral, nasal, and peripheral
(arcuate 1 and 2) regions (see Fig. 1) in the superior hemifield
were compared with their corresponding regions in the
inferior hemifield for POAG and PACG eyes at all severity
levels using the GEE model. The between-group comparison
was carried out by comparing the VF asymmetry patterns in
POAG and PACG groups, using the GEE model, accounting for
gender, refractive error, maximum IOP, and visual acuity.
Relationship Between mTD and PSD
To analyze whether the dominant pattern in the VFs was
generalized or localized loss, the relationship between mTD
and PSD was analyzed using a quadratic regression and the
relationship was compared between POAG and PACG groups
using the GEE model.
All statistical analyses were performed using the statistical
programming language R (R version 3.3.1; The Foundation for
Statistical Computing, Vienna, Austria, http://www.r-project.
org).
RESULTS
Demographic characteristics of POAG and PACG patients are
shown in Table 1. Within-group demographics: In POAG eyes,
the best-corrected VAs were significantly different across early,
moderate, and advanced severity levels (P ¼ 0.001, GEE
model). Similarly, the best-corrected VAs were significantly
different across early, moderate, and advanced severity levels
for PACG eyes (P < 0.001, GEE model). Although there was no
significant difference in refractive error among different
severity levels in POAG eyes, the difference was significant
(P¼ 0.01, GEE model) among different severity levels in PACG
eyes. Thirty-seven eyes of 29 POAG patients had a history of
IOL surgery. When these eyes were excluded, the refractive
FIGURE 1. GHT VF regions. Five GHT regions at the superior hemifield
and their corresponding five GHT regions at the inferior hemifield.
TABLE 1. Demographic Information of Patients
Characteristics Total Early Moderate Advanced P *
POAG patients
Subjects 327 207 124 80 –
Eyes 522 290 139 93 –
Age, y 54.1 (12.4) 53.1 (12.5) 55.1 (12.1) 55.9 (12.1) 0.72
Sex, % female 50.0 52.0 47.0 46.0 0.63
BCVA, logMAR 0.07 (0.08) 0.08 (0.08) 0.06 (0.08) 0.05 (0.09) 0.001
Refractive error, Diopters 4.3 (3.9) 4.1 (3.8) 4.5 (4.2) 4.4 (3.6) 0.37
Maximum IOP 16.0 (4.0) 16.4 (4.4) 15.7 (3.6) 15.3 (3.1) 0.03
mTD, dB 6.7 dB (6.2) 2.4 (1.9) 8.8 (2.1) 16.9 (4.2) < 0.001
PACG patients
Subjects 204 138 59 84 –
Eyes 375 198 68 109 –
Age, y 67.3 (8.9) 66.8 (8.4) 66.7 (9.2) 68.7 (9.5) 0.32
Sex, % female 60.7% 59.0% 68.0% 60.0% 0.64
BCVA, logMAR 0.01 (0.08) 0.03 (0.07) 0.01 (0.07) 0.02 (0.1) < 0.001
Refractive error, Diopters 0.35 (1.7) 0.08 (1.5) 0.53 (1.9) 0.70 (1.8) 0.01
Maximum IOP 15.6 (3.6) 15.7 (5.2) 15.6 (5.5) 15.4 (6.7) 0.96
mTD, dB 8.8 dB (8.7) 2.4 (2.0) 8.5 (1.7) 20.7 (5.9) < 0.001
Data represent mean (SD).
* P values calculated by applying ANOVA on GEE models comparing subgroups (severity) within each disease type.
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error in POAG eyes was4.4 (SD 3.9),4.2 (SD 3.8), and4.6
(SD 4.1) Diopter in early, moderate, and advanced stages,
respectively; there was no significant difference in refractive
error across severity levels. There was no significant difference
in age, sex, and maximum IOP across severity levels both in
POAG and PACG eyes.
Between-Group Demographics
The mTD of PACG eyes at the advanced stage of glaucoma was
significantly worse than the mTD of the POAG eyes (P < 0.001,
GEE model). On average, the PACG patients were significantly
older than POAG patients (67.3 vs. 54.1 years, P < 0.001, GEE
model). The PACG group also had a larger number of females
compared with the POAG group (P¼ 0.005, GEE model). The
refractive error in the POAG eyes was significantly smaller
(more negative) than that in the PACG eyes (P < 0.001, GEE
model). The maximum IOP in the POAG group was similar to
PACG group except in eyes at the early stage of glaucoma (P¼
0.04, GEE model). The best-corrected VA was significantly
different at all severity levels between POAG and PACG groups.
Regionwise Comparison of Hemifields
Table 2 demonstrates the regionwise superior-inferior hemi-
field asymmetry in POAG (top part) and PACG eyes (bottom
part). In POAG eyes, in the early stage, the average TD values in
the central, paracentral, and peripheral (arcuate 2) regions in
the superior hemifield were significantly worse compared with
corresponding regions in the inferior hemifield (P values <
0.001, 0.002, and 0.046, respectively; GEE models); however,
there was no significant difference in the remaining two
regions (P values were 0.22 and 0.96). In POAG eyes in the
moderate and advanced stages, all five GHT regions in the
superior hemifield had worse average TD values than those in
corresponding regions in the inferior hemifield (all P < 0.001)
(Figs. 2A–C; Table 2).
In PACG eyes in the early stage, the average TD value in the
central region of the superior hemifield was significantly worse
than its counterpart region in the inferior hemifield (P¼ 0.014,
GEE model); however, there was no significant difference in
the the average TD values of the remaining four regions (P
values: 0.37, 0.55, 0.43, and 0.98). In the moderate-stage PACG
eyes, the average TD values in both central and peripheral
(arcuate 2) regions of the superior hemifield were significantly
worse than those in the corresponding regions in the inferior
hemifield (P values: 0.028 and 0.019, respectively). There was
no significant difference in the average TD values in the
remaining three regions (P values: 0.47, 0.71, and 0.26,
respectively). In advanced-stage PACG eyes, the average TD
values in the central regions of the superior hemifield were
significantly worse than the average TD values in the
corresponding region in the inferior hemifield (P < 0.001),
whereas there was no significant difference in these values in
the remaining four regions (P values: 0.11, 0.42, 0.27, and 0.14,
respectively) (Figs. 2D–F).
Pointwise Comparison of Hemifields
Figure 3 shows the pointwise superior-inferior hemifield
asymmetry in POAG eyes (Figs. 3A–C) and PACG eyes (Figs.
3D–F). In early POAG eyes, all of the TD points in the central
region and a subset of TD points in the nasal, paracentral, and
peripheral (arcuate 1) regions in superior hemifield were
significantly worse than their counterparts in the inferior
hemifield (TD and P values are shown in Fig. 3A). In moderate
POAG eyes, the TD points in all GHT regions were significantly
worse than their counterparts in the inferior hemifield (TD and
TABLE 2. Between-Hemifield Comparison of GHT Regions
Region Subregion
Early, n ¼ 290 Moderate, n ¼ 139 Advanced, n ¼ 93
Average TD Values, dB P * Average TD Values, dB P * Average TD Values, dB P *
POAG, n ¼ 522
Central Superior 3.1 < 0.001 11.0 < 0.001 19.8 < 0.001
Inferior 1.7  5.9 11.3
Paracentral Superior 3.3 0.002 12.4 < 0.001 24.4 < 0.001
Inferior 2.2 8.1 15.8
Nasal Superior 4.2 0.22 16.1 < 0.001 26.6 < 0.001
Inferior 3.6 11.8 21.3
Peripheral, arcuate 1 Superior 2.2 0.96 10.7 < 0.001 20.9 0.001
Inferior 2.2 6.8 14.6
Peripheral, arcuate 2 Superior 1.6 0.04 7.2 < 0.001 16.0 < 0.001
Inferior 1.1 3.7 9.3
Region Subregion
Early, n ¼ 198 Moderate, n ¼ 68 Advanced, n ¼ 109
Average TD Values, dB P * Average TD Values, dB P * Average TD Values, dB P *
PACG, n ¼ 375
Central Superior 2.5 0.02 10.1 0.03 21.7 < 0.001
Inferior 1.6 7.3 16.6
Paracentral Superior 2.6 0.40 10.3 0.46 23.7 0.21
Inferior 2.3 9.3 21.9
Nasal Superior 3.5 0.54 11.9 0.85 25.7 0.39
Inferior 3.2 12.2 24.8
Peripheral, arcuate 1 Superior 2.3 0.38 8.7 0.22 22.5 0.27
Inferior 2.6 7.4 21.1
Peripheral, arcuate 2 Superior 1.9 0.98 7.5 0.02 19.4 0.09
Inferior 1.9 5.2 17.2
* P values from GEE model that compares each GHT region asymmetry with corresponding test-retest GHT region asymmetry.
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P values are shown in Fig. 3B). In advanced POAG eyes, the TD
values of all TD points in all GHT regions were significantly
worse than their counterparts in the inferior hemifield (TD and
P values are shown in Fig. 3C).
In early PACG eyes, a subset of TD points in the central and
paracentral regions in the superior hemifield had significantly
lower values than their counterparts in the inferior hemifield
(TD and P values are shown in Fig. 3D). In moderate PACG
eyes, a subset of TD points in the central, paracentral, and
peripheral (arcuate 1 and arcuate 2) regions in the superior
hemifield had significantly lower values than their counterparts
in the inferior hemifield (TD and P values are shown in Fig. 3E).
In advanced PACG eyes, a subset of TD points in the central,
paracentral, and peripheral (arcuate 1 and arcuate 2) regions in
the superior hemifield were significantly lower than their
counterparts in the inferior hemifield (TD and P values are
shown in Fig. 3F).
POAG and PACG Comparison
Figure 4 (panels from left to right: central, paracentral, nasal,
arcuate 1, and arcuate 2, respectively) shows the relationship
between the superior-inferior hemifield asymmetry plotted
against mTD in POAG eyes (presented in blue) and PACG eyes
(presented in orange). The best-fit quadratic curves for POAG
and PACG groups follow a U-shape characteristic (except for
the nasal region of PACG eyes), suggesting in all GHT regions,
superior VF loss tended to be more pronounced than inferior
FIGURE 2. Between-hemifield comparison of GHT regions. (A–C) represent the patterns of VF defect of the POAG group and (D–F) show the
superior-inferior asymmetric patterns of defect of the PACG group. (A) and (D) represent early stage, (B) and (E) represent moderate stage, and (C)
and (F) represent advanced stage, respectively. Black areas show significant superior-inferior VF asymmety; regional TD values in the superior
hemifield are significantly worse than theircounterpart in the inferior hemifeld (P  0.05).
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region. Moreover, this tendency is more pronounced in POAG
eyes than in PACG eyes, in the moderate stage of the disease in
particular, as suggested by the greater distance between the
curves of POAG and PACG.
The hemifield asymmetry (superior was worse than inferior
hemifield) in all POAG eyes was significantly larger than that in
all PACG eyes in central, paracentral, and nasal regions (P
values: 0.041, 0.049, 0.035, GEE models), whereas the
asymmetry was not significant in peripheral regions (arcuate
1 and arcuate 2 P values: 0.09 and 0.07, respectively) when
adjusted for sex, mTD, maximum IOP, and refractive error.
Figure 5 shows the comparison of the relationships
between PSD and mTD, between POAG and PACG eyes. As
was expected, the PSD and mTD followed quadratic relation-
ship; PSD worsened as mTD worsened up to the point mTD
reaches approximately 17.5 dB and the PSD returns to fall
beyond this point. The best-fit quadratic curves for the POAG
and PACG groups demonstrated that the PACG group had
lower PSD values for given mTD values. We further analyzed
this finding by fitting a GEE model with PSD as the dependent
variable and diagnosis as the primary independent variable
while controlling for sex, maximum IOP, refractive error, mTD,
and (mTD)2 to account for the quartic characteristic of the
FIGURE 3. Comparison of TD values between superior and inferior hemifields. (A–C) belong to the POAG group and represent eyes in the early,
moderate, and advanced stages of glaucoma, respectively. (D–F) show the patterns of defect of the PACG group corresponding to eyes in the early,
moderate, and advanced stages of glaucoma, respectively. Black areas show TD values in superior hemifield test locations were significantly worse
than their corresponding locations in the inferior henmifield (P  0.05). Shown at each superior location: mTD value at the top and P value at the
bottom. P value reflects the significance of the difference between the mTD of the superior location and the inferior location. Shown at each
inferior location: mTD value at that location.
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model. The model suggested that POAG eyes had significantly
greater PSD values for a given mTD than the PACG eyes (P <
0.001, GEE model) which further emphasizes that POAG eyes
had more localized patterns of defect compared with PACG
eyes or in other words, PACG eyes had more generalized or
diffuse loss compared with POAG eyes.
DISCUSSION
In this study, we compared the superior-inferior asymmetric
patterns of VF loss in POAG and PACG eyes. In early-stage
POAG eyes, the hemifield asymmetry (superior worse than
inferior) was significant in central, paracentral, and peripheral
(arcuate 2) regions. In POAG eyes in moderate and advanced
stages, all five GHT regions had significant hemifield asymme-
try. In PACG eyes, in contrast, this finding was observed in
fewer regions; only one region (central) in early and asvanced
stages, and two regions (central and peripheral) in moderate
stage. In addition, POAG eyes tended to have more localized
loss than PACG eyes, suggested by higher PSD values for given
mTD values accounting for all covariates.
Among the comparisons of demographic parameters
between POAG and PACG eyes, a larger number of females
was observed in PACG than in POAG (see Table 1). This is in
agreement with previous studies that suggested that females
are more likely to develop PACG35,36,42,43 and sex is even an
independent risk factor for developing PACG.12 We also
observed that myopia was more associated with POAG,
whereas hyperopia was more associated with PACG, agreeing
with previous reports.16,44
Gazzard and colleagues37 reported that the paracentral and
peripheral (arcuate 2) regions in the superior hemifield were
more damaged than their counterpart regions in the inferior
hemifield in early POAG eyes, whereas in moderately damaged
eyes, all GHT regions in superior hemifield were significantly
more damaged than their counterpart regions in the inferior
hemifield. This is in agreement with the current results (see
Figs. 2A–C). In advanced POAG eyes in the same study, only the
central region in the superior hemifield was more damaged
than the corresponding region in the inferior hemifield,
whereas all GHT regions in the superior hemifield were
significantly worse than the corrsponding regions in the
inferior hemifield in our study. One possible reason for this
disagreement would be the different cutoff values adopted to
define the severity levels. In the previous study, the advanced
group was defined as mean deviation (MD) <20 dB, which is
much more advanced than that in the current study (12 dB).
As a result, in the previous study, the VF damage reached into
the inferior hemifield, except for the central area which usually
is preserved until the very late stage of glaucoma.
Gazzard and colleagues37 reported that no region showed
significant superior-inferior asymmetry in early PACG eyes,
whereas our study showed a significant superior-inferior
asymmetry in the central region. In that study, all GHT regions
except the nasal region showed significant asymmetry in
moderately glaucomatous eyes, whereas we observed just
central and peripheral (arcuate 2) regions with significant
superior-inferior asymmetry. Finally, both studies are in
agreement that the central region of the advanced PACG eyes
has a significant superior-inferior asymmetry (see Figs. 2D–F).
On the other hand, Atalay and associates38 reported that there
is significant superior-inferior asymmetry in the paracentral
region in the early stage, central, and paracentral regions in the
moderate stage, and all GHT regions in the advanced stage of
PACG eyes. Different criteria used in defining stages of the
disease could be one reason for the differences in the patterns
of VF defect among these studies. However, all studies are in
agreement that the central region of the moderate and
advanced PACG eyes is more severely damaged in the superior
hemifield compared with the inferior hemifield.
In the current study, POAG eyes had a higher PSD than that
in PACG eyes for given MD values, which suggests more
localized patterns of loss in POAG eyes compared with PACG
eyes and more diffuse VF damage in PACG eyes compared with
POAG eyes. This finding is consistent with other previous
reports, despite the difference of ethnicity: Gazzard et al.37
(mainly Chinese subjects), Rhee et al.34 (mainly Korean
subjects), and Boland and associates (mainly Caucasian
subjects).35 Ngo et al. (mainly Chinese subjects) also reported
FIGURE 4. Scatterplot and second-order polynomial fitting the difference between the superior and inferior hemifields of the POAG (blue color) and
PACG eyes (orange color) across all severity levels. From left to right: central, paracentral, nasal, peripheral (arcuate 1), and peripheral (arcuate 2)
regions.
FIGURE 5. Scatterplot of PSD versus mTD for eyes with POAG (in blue
circles) and PACG (in orange crosses).
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similar observations, although they reported that the differ-
ence was not statistically significant.36
The current study consisted of Japanese patients, in whom
normal tension glaucoma (NTG) prevalence is high compared
with Caucasians.45 Therefore, in the current study, this fact
may have influenced the appearance of the localized VF
damage in POAG eyes and observing more diffuse VF damage
in PACG eyes. Diffuse VF damage in PACG eyes may be
explained by the differences in the optic disc appearance of
these two groups. In PACG eyes, optic disc pallor is usually a
feature of acute angle closure; however, there is a report that
the optic disc may be pale in chronic PACG rather than having
cupping and/or optic disc rim notching, which are characteric
of optic disc change in POAG.46 It should be noted that POAG
eyes with localized VF defect are more likely to be diagnosed as
glaucoma than those with diffuse optic disc enlargement. On
the other hand, in a group of patients with PACG, it is more
likely that the initial diagnosis was based on elevated IOP and
narrow angle, irrespective of the type of optic disc damage
they presented. Thus, the current results may be biased in this
respect. In other words, it is likely that the patients with POAG
at the time of diagnosis had normal IOPs and the diagnosis was
made on the basis of suspicious discs (maybe more localized
losses), as opposed to the PACG group, in whom IOP was likely
elevated at the time of diagnosis. The current results may be
biased by these differences. However, in the current study,
PACG eyes with previous angle-closure attack and IOP greater
than 30 mm Hg were excluded. Moreover, the effect of this
bias would be small, if any, in advanced-stage disease.
Nonetheless, there was a similar/continuous VF defect pattern
in POAG eyes from early to advanced stage. Thus, there may be
some ascertainment bias in the current results; however, the
influence of this bias would be relatively small.
Gazzard et al.47 reported that IOP alone was less associated
with the severity of VF loss in POAG eyes than in PACG eyes,
suggesting there may be other factors attributing to the VF
damage in POAG eyes.37 Because the IOP is not significanlty
different between the two groups in our study, we also suggest
that there may be other factors attributing to the difference in
VF patterns of loss between POAG and PACG eyes. In
particular, PACG eyes often have intermittent/irreversible
(without interventions) sharp spike(s) of IOP elevation.
Moreover, under highly elevated IOP, the damage may be
closer to ischemia of the optic disc.12 VF damage in ischemic
optic neuropathy is predominant in the inferior hemifield,48
and also, we have recently suggested VF damage in POAG
patients who smoke tends to be in the inferior hemifield.49
These findings imply that the diffuse VF damage both in
superior and inferior hemifields in the PACG eyes may be
caused by the elevated IOP itself and also induced ischemia.
Also, as speculated in Boland et al.,35 PACG may not be related
to increased susceptability in the optic disc and retina, such as
abnormally compliant disc connective tissues that have greater
vulnerability to IOP. On the other hand, POAG, in particular in
normal-tension glaucoma, often occurs at IOP levels that are
tolerated by most eyes and may have idiosyncratic defects in
nerve head structure or ganglion cell susceptibility to
apoptosis, which may be underlying the fact that inferotem-
poral rim loss is the most common optic disc change in
POAG.48 These factors may also have contributed to the
difference of VF damage between POAG and PACG eyes,
observed in the current study. Another major difference may
come from the study sample size. The current study analyzed a
much larger dataset of 522 POAG eyes and 375 PACG eyes to
allow the conducting of a robust comparison of VF patterns of
defect across several severities levels.
One of the limitations of our study is that the VF damage
was investigated only in a cross-sectional manner. A follow-up
study would be needed to characterize temporal VF progres-
sion patterns. Another limitation is that axial length measure-
ments were not obtained, because the current data were
obtained from a real-world clinic where axial length is not
routinely measured. Also, the IOP data without treatment were
unknown. Thus, the level of IOP when the damage to the optic
discs occurred is unknown, and it would be suspected that
they were much higher in the PACG group. These variables
may be related to the VF change, and a future study should be
conducted measuring these variables.
In conclusion, the current study suggested VF damage is
more pronounced in the superior hemifield than in the inferior
hemifield both in POAG and PACG eyes; however, this
tendency was less obvious in PACG eyes. In addition, the VF
damage in PACG eyes is more diffuse than that in POAG eyes.
These findings may be attributed to different underlying
pathologies of POAG and PACG. This fact also implies that
optimal therapeutic approaches may be different.
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